Cargando…

Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England

OBJECTIVES: The introduction of primary Human Papillomavirus (HPV) testing in the National Health Service (NHS) Cervical Screening Programme in England means the screening interval for 25–49 years can be extended from 3 to 5 years. We explored women’s responses to the proposed interval extension. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nemec, Martin, Waller, Jo, Barnes, Jessica, Marlow, Laura A V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073390/ https://www.ncbi.nlm.nih.gov/pubmed/35508345 http://dx.doi.org/10.1136/bmjopen-2021-058635

Ejemplares similares

Testing key messages about extending cervical screening intervals
por: A.V. Marlow, Laura, et al.
Publicado: (2022)

Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study
por: Hill, Emily, et al.
Publicado: (2020)

Information needs among women taking part in primary HPV screening in England: a content analysis
por: Marlow, Laura, et al.
Publicado: (2020)

Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme
por: McBride, Emily, et al.
Publicado: (2016)

Public awareness of and responses to media coverage of invitation errors in the Breast Screening Programme in England: a cross-sectional population survey
por: Ghanouni, Alex, et al.
Publicado: (2019)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening
por: Yang, Qing, et al.
Publicado: (2022)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results
por: Smith, Laurie W, et al.
Publicado: (2021)

Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Psychological Impact of the Galleri test (sIG(n)al): protocol for a longitudinal evaluation of the psychological impact of receiving a cancer signal in the NHS-Galleri trial
por: Marlow, Laura A V, et al.
Publicado: (2023)

Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study
por: Johnson, Helen C, et al.
Publicado: (2017)

Examining the information needed for acceptance of deintensified screening programmes: qualitative focus groups about cervical screening in Australia
por: Dodd, Rachael H, et al.
Publicado: (2019)

Understanding cervical screening non-attendance among ethnic minority women in England
por: Marlow, L A V, et al.
Publicado: (2015)

Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England
por: Marlow, Laura, et al.
Publicado: (2019)

Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2018)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review
por: Dzobo, Mathias, et al.
Publicado: (2023)

Patterns of anxiety and distress over 12 months following participation in HPV primary screening
por: Marlow, Laura A V, et al.
Publicado: (2022)

Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women
por: Marlow, Laura A V, et al.
Publicado: (2008)

Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study
por: Waller, Jo, et al.
Publicado: (2013)

Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England
por: Drysdale, Hannah, et al.
Publicado: (2022)

Decision‐making about cervical screening in a heterogeneous sample of nonparticipants: A qualitative interview study
por: Marlow, Laura A.V., et al.
Publicado: (2018)

Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States
por: Gray, Aaliyah, et al.
Publicado: (2023)

Secondary analyses to test the impact on inequalities and uptake of the schools-based human papillomavirus (HPV) vaccination programme by stage of implementation of a new consent policy in the south-west of England
por: Fisher, Harriet, et al.
Publicado: (2021)

Using Implementation Mapping to increase uptake and use of Salud en Mis Manos: A breast and cervical cancer screening and HPV vaccination intervention for Latinas
por: Savas, Lara S., et al.
Publicado: (2023)

Role of ethnicity in human papillomavirus vaccination uptake: a cross-sectional study of girls from ethnic minority groups attending London schools
por: Rockliffe, Lauren, et al.
Publicado: (2017)

Acceptance and Willingness to Pay for Vaccine Against Human Papilloma Virus (HPV) Among Parents of Boys in Central Vietnam
por: Nguyen, Lan Hoang, et al.
Publicado: (2022)

Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022
por: Hou, Jinfeng, et al.
Publicado: (2023)

The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2021)

Perspectives of attenders and non-attenders to SARS-CoV-2 asymptomatic community testing in England: a qualitative interview study
por: Jayes, Leah, et al.
Publicado: (2022)

Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women
por: Ma'som, Mahirah, et al.
Publicado: (2016)

Women’s Knowledge and Attitudes Towards Cervical Cancer Screening in Morocco
por: Bendahhou, Karima, et al.
Publicado: (2023)

Determinants of COVID-19 vaccine acceptance and access among people experiencing homelessness in Germany: A qualitative interview study
por: Grune, Julianna, et al.
Publicado: (2023)

Corrigendum: Determinants of COVID-19 vaccine acceptance and access among people experiencing homelessness in Germany: a qualitative interview study
por: Grune, Julianna, et al.
Publicado: (2023)

Qualitative study of barriers to cervical cancer screening among Nigerian women
por: Isa Modibbo, Fatima, et al.
Publicado: (2016)

Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
por: McWilliams, Lorna, et al.
Publicado: (2021)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)
por: Stanczuk, Grazyna, et al.
Publicado: (2016)

Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women
por: Adhikari, Indira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsr6d3v7g3gmjks9sqtc48e6ma